LTP — Ltr Pharma Balance Sheet
0.000.00%
Last trade - 00:00- AU$70.58m
- AU$36.51m
- AU$0.05m
Annual balance sheet for Ltr Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 0.146 | 1.91 | 1.73 | 3.1 |
| Net Total Receivables | — | — | — | 0.265 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 0.146 | 1.95 | 1.79 | 3.37 |
| Net Property, Plant And Equipment | — | — | — | 0.002 |
| Long Term Notes Receivable | ||||
| Total Assets | 0.423 | 2.25 | 2.09 | 3.37 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.464 | 0.476 | 0.021 | 0.429 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.464 | 0.476 | 0.021 | 0.429 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | -0.041 | 1.77 | 2.07 | 2.94 |
| Total Liabilities & Shareholders' Equity | 0.423 | 2.25 | 2.09 | 3.37 |
| Total Common Shares Outstanding |